Jesus Berdeja

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Topic:
    Consultant
    Date added:
    02/28/2023
    Date updated:
    05/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Celgene
    Topic:
    Consultant
    Date added:
    02/28/2023
    Date updated:
    05/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    CRISPR Therapeutics
    Topic:
    Consultant
    Date added:
    02/28/2023
    Date updated:
    05/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen
    Topic:
    Consultant
    Date added:
    02/28/2023
    Date updated:
    05/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Kite Pharma
    Topic:
    Consultant
    Date added:
    02/28/2023
    Date updated:
    05/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Legend Biotech
    Topic:
    Consultant
    Date added:
    02/28/2023
    Date updated:
    05/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Roche
    Topic:
    Consultant
    Date added:
    02/28/2023
    Date updated:
    05/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Takeda
    Topic:
    Consultant
    Date added:
    02/28/2023
    Date updated:
    05/10/2024

Pages

Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice